NSD2 is a conserved driver of metastatic prostate cancer progression
- Alvaro Aytes
- , Arianna Giacobbe
- , Antonina Mitrofanova
- , Katia Ruggero
- , Joanna Cyrta
- , Juan Arriaga
- , Luis Palomero
- , Sonia Farran-Matas
- , Mark A. Rubin
- , Michael M. Shen
- , Andrea Califano
- , Cory Abate-Shen
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.